221 related articles for article (PubMed ID: 34912234)
1. Antiphospholipid Antibodies From Women With Pregnancy Morbidity and Vascular Thrombosis Induce Endothelial Mitochondrial Dysfunction, mTOR Activation, and Autophagy.
Rodríguez CM; Velásquez-Berrío M; Rúa C; Viana M; Abrahams VM; Cadavid AP; Alvarez AM
Front Physiol; 2021; 12():706743. PubMed ID: 34912234
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the activation of endothelial nitric oxide synthase and nitrosative stress biomarkers by aspirin triggered lipoxins: A possible mechanism of action of aspirin in the antiphospholipid syndrome.
Granada-Gómez M; Velásquez-Berrío M; Molina CR; Martín SS; Escudero C; Alvarez AM; Cadavid AP
Am J Reprod Immunol; 2023 Aug; 90(2):e13753. PubMed ID: 37491919
[TBL] [Abstract][Full Text] [Related]
3. Obstetric Antiphospholipid Syndrome: An Approach from Glycans of the Immunoglobulin G.
Alvarez AM; Gomez-Gutierrez AM; Bueno-Sánchez JC; Rúa-Molina C; Cadavid AP
J Hum Reprod Sci; 2021; 14(1):97-100. PubMed ID: 34084001
[TBL] [Abstract][Full Text] [Related]
4. Differences in Endothelial Activation and Dysfunction Induced by Antiphospholipid Antibodies Among Groups of Patients With Thrombotic, Refractory, and Non-refractory Antiphospholipid Syndrome.
Velásquez M; Peláez LF; Rojas M; Narváez-Sánchez R; Velásquez JA; Escudero C; San Martín S; Cadavid ÁP
Front Physiol; 2021; 12():764702. PubMed ID: 34925061
[TBL] [Abstract][Full Text] [Related]
5. Differences in Antiphospholipid Antibody Profile between Patients with Obstetric and Thrombotic Antiphospholipid Syndrome.
Anunciación-Llunell A; Muñoz C; Roggenbuck D; Frasca S; Pardos-Gea J; Esteve-Valverde E; Alijotas-Reig J; Miró-Mur F
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361608
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling identifies distinct molecular signatures in thrombotic and obstetric antiphospholipid syndrome.
Ripoll VM; Pregnolato F; Mazza S; Bodio C; Grossi C; McDonnell T; Pericleous C; Meroni PL; Isenberg DA; Rahman A; Giles IP
J Autoimmun; 2018 Sep; 93():114-123. PubMed ID: 30033000
[TBL] [Abstract][Full Text] [Related]
7. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
[TBL] [Abstract][Full Text] [Related]
8. Anti-β2GPI domain 1 antibodies stratify high risk of thrombosis and late pregnancy morbidity in a large cohort of Chinese patients with antiphospholipid syndrome.
Liu T; Gu J; Wan L; Hu Q; Teng J; Liu H; Cheng X; Ye J; Su Y; Sun Y; Chi H; Zhou Z; Jia J; Wang Z; Zhou J; Norman GL; Wang X; Yang C; Shi H
Thromb Res; 2020 Jan; 185():142-149. PubMed ID: 31816554
[TBL] [Abstract][Full Text] [Related]
9. Modulation of antiphospholipid antibodies-induced trophoblast damage by different drugs used to prevent pregnancy morbidity associated with antiphospholipid syndrome.
Alvarez AM; Balcázar N; San Martín S; Markert UR; Cadavid AP
Am J Reprod Immunol; 2017 Apr; 77(4):. PubMed ID: 28132398
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies.
Bala MM; Paszek E; Lesniak W; Wloch-Kopec D; Jasinska K; Undas A
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012534. PubMed ID: 30004572
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study.
de Jesús GR; Sciascia S; Andrade D; Barbhaiya M; Tektonidou M; Banzato A; Pengo V; Ji L; Meroni PL; Ugarte A; Cohen H; Branch DW; Andreoli L; Belmont HM; Fortin PR; Petri M; Rodriguez E; Cervera R; Knight JS; Atsumi T; Willis R; Nascimento IS; Rosa R; Erkan D; Levy RA;
BJOG; 2019 Apr; 126(5):656-661. PubMed ID: 30222236
[TBL] [Abstract][Full Text] [Related]
12. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
[TBL] [Abstract][Full Text] [Related]
13. Molecular Mechanisms of "Antiphospholipid Antibodies" and Their Paradoxical Role in the Pathogenesis of "Seronegative APS".
Misasi R; Longo A; Recalchi S; Caissutti D; Riitano G; Manganelli V; Garofalo T; Sorice M; Capozzi A
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182499
[TBL] [Abstract][Full Text] [Related]
14. Purified IgG from patients with obstetric but not IgG from non-obstetric antiphospholipid syndrome inhibit trophoblast invasion.
Poulton K; Ripoll VM; Pericleous C; Meroni PL; Gerosa M; Ioannou Y; Rahman A; Giles IP
Am J Reprod Immunol; 2015 May; 73(5):390-401. PubMed ID: 25469631
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of Endothelial Dysfunction in Antiphospholipid Syndrome: Association With Clinical Manifestations.
Velásquez M; Rojas M; Abrahams VM; Escudero C; Cadavid ÁP
Front Physiol; 2018; 9():1840. PubMed ID: 30627104
[TBL] [Abstract][Full Text] [Related]
16. Relevance of non-criteria antiphospholipid antibodies titers among patients with antiphospholipid syndrome and patients with systemic lupus erythematosus.
Urrego-Callejas T; Hernández A; Ruiz Giraldo S; Frade-Sosa B; Vanegas-García AL; Muñoz CH; Rua C; Duque Botero J; González LA; Vásquez G; Gómez-Puerta JA
Reumatol Clin (Engl Ed); 2023 Apr; 19(4):197-203. PubMed ID: 37061281
[TBL] [Abstract][Full Text] [Related]
17. Does seronegative obstetric APS exist? "pro" and "cons".
Conti F; Andreoli L; Crisafulli F; Mancuso S; Truglia S; Tektonidou MG
Autoimmun Rev; 2019 Dec; 18(12):102407. PubMed ID: 31639518
[TBL] [Abstract][Full Text] [Related]
18. The presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study.
da Rosa GP; Sousa-Pinto B; Ferreira E; Araújo O; Barilaro G; Bettencourt P; Cervera R; Espinosa G
Arthritis Res Ther; 2022 Jan; 24(1):9. PubMed ID: 34980238
[TBL] [Abstract][Full Text] [Related]
19. Additional risk factors associated with thrombosis and pregnancy morbidity in a unique cohort of antiphospholipid antibody-positive patients.
Li C; Zuo Y; Zhang S; Makris UE; Karp DR; Li Z
Chin Med J (Engl); 2022 Mar; 135(6):658-664. PubMed ID: 35143425
[TBL] [Abstract][Full Text] [Related]
20. Added value of antiphosphatidylserine/prothrombin antibodies in the workup of obstetric antiphospholipid syndrome: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.
Vandevelde A; Gris JC; Moore GW; Musiał J; Zuily S; Wahl D; Devreese KMJ
J Thromb Haemost; 2023 Jul; 21(7):1981-1994. PubMed ID: 37061133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
